Skip to main content

Revvityブログ

発見から治療までのイノベーションを促進

The significance of longitudinal in vivo imaging in advancing drug discovery.
Small Molecule Drug Discovery November 8, 2024 - 3 min read
Cancer
Why you should use 3D cell models for high throughput screening.
Cancer
Recommendations from the AML MRD advisory board and the utility of Mimix Reference Standards in AML research.
Cancer
Fluorescence imaging is comparable to PET in early detection of tumor metabolism.
Cancer
The top 7 attributes of cell line-derived reference standards for oncology assays.
Cancer
Can tumors be reverse-engineered to produce a local-acting ‘vaccine’?

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ